 John Haran
Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza, Human | 3 | 2014 | 119 | 1.190 |
Why?
| | Emergency Service, Hospital | 3 | 2015 | 361 | 1.100 |
Why?
| | Anti-Bacterial Agents | 3 | 2015 | 378 | 1.050 |
Why?
| | Soft Tissue Infections | 2 | 2015 | 24 | 0.830 |
Why?
| | Skin Diseases, Bacterial | 1 | 2015 | 7 | 0.690 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2014 | 23 | 0.630 |
Why?
| | Hemagglutinins, Viral | 1 | 2014 | 28 | 0.630 |
Why?
| | Diarrhea | 1 | 2014 | 44 | 0.630 |
Why?
| | Respiratory Tract Infections | 1 | 2014 | 52 | 0.620 |
Why?
| | Pneumonia, Bacterial | 1 | 2013 | 47 | 0.560 |
Why?
| | Antibodies, Viral | 1 | 2014 | 221 | 0.560 |
Why?
| | Bacterial Infections | 1 | 2012 | 85 | 0.530 |
Why?
| | Virus Diseases | 1 | 2012 | 108 | 0.510 |
Why?
| | C-Reactive Protein | 1 | 2012 | 167 | 0.510 |
Why?
| | Cytokines | 1 | 2013 | 713 | 0.450 |
Why?
| | Influenza A Virus, H1N1 Subtype | 3 | 2014 | 73 | 0.430 |
Why?
| | Adult | 7 | 2015 | 9549 | 0.340 |
Why?
| | Prospective Studies | 3 | 2014 | 1623 | 0.320 |
Why?
| | ROC Curve | 2 | 2013 | 141 | 0.280 |
Why?
| | Cohort Studies | 3 | 2015 | 1381 | 0.280 |
Why?
| | Middle Aged | 6 | 2015 | 9780 | 0.270 |
Why?
| | Male | 8 | 2015 | 17076 | 0.260 |
Why?
| | Female | 7 | 2015 | 18595 | 0.240 |
Why?
| | Virus Replication | 1 | 2002 | 263 | 0.240 |
Why?
| | Monocytes | 1 | 2002 | 304 | 0.240 |
Why?
| | Aged | 5 | 2015 | 7555 | 0.230 |
Why?
| | Humans | 9 | 2015 | 33740 | 0.200 |
Why?
| | HIV-1 | 1 | 2002 | 578 | 0.190 |
Why?
| | HIV Infections | 1 | 2002 | 642 | 0.180 |
Why?
| | Adolescent | 3 | 2013 | 3941 | 0.170 |
Why?
| | Hemagglutination Inhibition Tests | 1 | 2014 | 15 | 0.160 |
Why?
| | Antibody Formation | 1 | 2014 | 103 | 0.160 |
Why?
| | Skin Diseases, Infectious | 1 | 2013 | 7 | 0.160 |
Why?
| | Administration, Oral | 1 | 2014 | 200 | 0.150 |
Why?
| | HLA-DR3 Antigen | 1 | 2013 | 2 | 0.150 |
Why?
| | Femoral Nerve | 1 | 2013 | 3 | 0.150 |
Why?
| | Aged, 80 and over | 4 | 2013 | 2838 | 0.150 |
Why?
| | Guideline Adherence | 1 | 2015 | 228 | 0.150 |
Why?
| | Sex Factors | 1 | 2015 | 643 | 0.150 |
Why?
| | Nerve Block | 1 | 2013 | 19 | 0.150 |
Why?
| | Morphine | 1 | 2013 | 36 | 0.150 |
Why?
| | Influenza Vaccines | 1 | 2013 | 41 | 0.150 |
Why?
| | Antibodies, Neutralizing | 1 | 2014 | 97 | 0.150 |
Why?
| | Hip Fractures | 1 | 2013 | 54 | 0.140 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 172 | 0.140 |
Why?
| | Odds Ratio | 1 | 2014 | 600 | 0.140 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 445 | 0.140 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2013 | 166 | 0.140 |
Why?
| | Trauma Centers | 1 | 2012 | 34 | 0.140 |
Why?
| | Disease Progression | 1 | 2014 | 475 | 0.140 |
Why?
| | Multivariate Analysis | 1 | 2014 | 720 | 0.140 |
Why?
| | European Continental Ancestry Group | 1 | 2014 | 413 | 0.130 |
Why?
| | Age Factors | 1 | 2015 | 1085 | 0.130 |
Why?
| | Emergency Medical Services | 1 | 2013 | 127 | 0.130 |
Why?
| | Logistic Models | 1 | 2014 | 878 | 0.130 |
Why?
| | African Americans | 1 | 2014 | 375 | 0.130 |
Why?
| | Analysis of Variance | 1 | 2012 | 535 | 0.130 |
Why?
| | Pain | 1 | 2013 | 217 | 0.120 |
Why?
| | Diagnosis, Differential | 1 | 2013 | 634 | 0.120 |
Why?
| | Hispanic Americans | 1 | 2014 | 368 | 0.120 |
Why?
| | Predictive Value of Tests | 1 | 2012 | 683 | 0.120 |
Why?
| | Sensitivity and Specificity | 1 | 2012 | 782 | 0.120 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2013 | 526 | 0.110 |
Why?
| | Young Adult | 2 | 2013 | 2084 | 0.110 |
Why?
| | Severity of Illness Index | 1 | 2013 | 851 | 0.110 |
Why?
| | Paecilomyces | 1 | 2008 | 2 | 0.100 |
Why?
| | Bursitis | 1 | 2008 | 11 | 0.100 |
Why?
| | Mycoses | 1 | 2008 | 39 | 0.100 |
Why?
| | Risk Factors | 1 | 2014 | 2973 | 0.090 |
Why?
| | Coculture Techniques | 1 | 2002 | 79 | 0.070 |
Why?
| | Child | 2 | 2013 | 2606 | 0.070 |
Why?
| | Hospitals, Urban | 1 | 2013 | 36 | 0.040 |
Why?
| | Infusions, Parenteral | 1 | 2013 | 21 | 0.040 |
Why?
| | New England | 1 | 2013 | 191 | 0.040 |
Why?
| | Analgesia | 1 | 2013 | 20 | 0.040 |
Why?
| | Confidence Intervals | 1 | 2013 | 241 | 0.040 |
Why?
| | Viral Load | 1 | 2013 | 159 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 101 | 0.040 |
Why?
| | Ultrasonography | 1 | 2013 | 300 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2013 | 169 | 0.030 |
Why?
| | Infant | 1 | 2013 | 947 | 0.030 |
Why?
| | Lung | 1 | 2013 | 446 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2013 | 946 | 0.030 |
Why?
| | Quality of Health Care | 1 | 2013 | 365 | 0.030 |
Why?
| | Child, Preschool | 1 | 2013 | 1300 | 0.030 |
Why?
| | Ketoconazole | 1 | 2008 | 6 | 0.030 |
Why?
| | Drug Resistance, Multiple, Fungal | 1 | 2008 | 3 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2008 | 57 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2013 | 2505 | 0.020 |
Why?
| | Animals | 2 | 2013 | 14760 | 0.020 |
Why?
| | Mice | 1 | 2013 | 7407 | 0.020 |
Why?
|
|
Haran's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|